Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations. | Cancer Chemother Pharmacol | 2024 | 38300251 | PubTator, text mining | PubMed |
| Influence of N-acetyltransferase 2 polymorphisms and clinical variables on liver function profile of tuberculosis patients. | Expert Rev Clin Pharmacol | 2024 | 38287694 | PubTator, text mining | PubMed |
| Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in Urine. | Molecules | 2024 | 38257250 | PubTator, text mining | PubMed |
| Stevens-Johnson Syndrome in a Patient on Concomitant Treatment with Levetiracetam and Trimethoprim/Sulfamethoxazole. | Am J Case Rep | 2024 | 38247161 | PubTator, text mining | PubMed |
| The role of tryptophan derivatives as anti-kinetoplastid agents. | Heliyon | 2024 | 38187297 | PubTator, text mining | PubMed |
| Towards pharmacogenomics-guided tuberculosis (TB) therapy: N-acetyltransferase-2 genotypes among TB-infected Kenyans of mixed ethnicity. | BMC Med Genomics | 2024 | 38184575 | PubTator, text mining | PubMed |
| The CEPH aging cohort and biobank: a valuable collection of biological samples from exceptionally long-lived French individuals and their offspring for longevity studies. | Geroscience | 2024 | 38141157 | PubTator, text mining | PubMed |
| Relevance of NAT2 genotype and clinical factors to risk for antituberculosis drug-induced liver injury. | Pharmacogenomics | 2024 | 38131213 | PubTator, text mining | PubMed |
| Bioinformatics and machine learning driven key genes screening for hepatocellular carcinoma. | Biochem Biophys Rep | 2024 | 38107663 | PubTator, text mining | PubMed |
| Evaluating interactions of polygenic risk scores and NAT2 genotypes with tobacco smoking in bladder cancer risk. | Int J Cancer | 2024 | 37728483 | PubTator, text mining | PubMed |
| Synergistic polymorphic interactions of phase II metabolizing genes and their association toward lung cancer susceptibility in North Indians. | Int J Environ Health Res | 2024 | 36251537 | PubTator, text mining | PubMed |
| Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis, and outcomes. | Front Pharmacol | 2023 | 38283839 | PubTator, text mining | PubMed |
| The genetic risk of acute lymphoblastic leukemia and its implications for children of Latin American origin. | Front Oncol | 2023 | 38264740 | PubTator, text mining | PubMed |
| Association between interleukin-12 +1188A/C polymorphism and the risk of tuberculosis: A meta-analysis. | Afr Health Sci | 2023 | 38223634 | PubTator, text mining | PubMed |
| Long Follow-Up Times Weaken Observational Diet-Cancer Study Outcomes: Evidence from Studies of Meat and Cancer Risk. | Nutrients | 2023 | 38201857 | PubTator, text mining | PubMed |
| Metabolism-Related Prognostic Biomarkers, Purine Metabolism and Anti-Tumor Immunity in Colon Adenocarcinoma. | Front Biosci (Landmark Ed) | 2023 | 38179743 | PubTator, text mining | PubMed |
| The Role of Therapeutic Drug Monitoring in Slow Response Extra-Pulmonary Tuberculosis Treatment: A Case Report. | Cureus | 2023 | 38161565 | PubTator, text mining | PubMed |
| Caffeine and Its Interactions with Antiseizure Medications-Is There a Correlation between Preclinical and Clinical Data? | Int J Mol Sci | 2023 | 38139396 | PubTator, text mining | PubMed |
| Metabolomic Signatures of Treatment Response in Bladder Cancer. | Int J Mol Sci | 2023 | 38139377 | PubTator, text mining | PubMed |
| Direct Comparative Analysis of a Pharmacogenomics Panel with PacBio Hifi® Long-Read and Illumina Short-Read Sequencing. | J Pers Med | 2023 | 38138882 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=9